← Back to headlines
Johnson & Johnson Reports Strong Q2 Earnings, Raises Full-Year Forecast
Johnson & Johnson reported second-quarter earnings that surpassed Wall Street estimates, driven by the strength of its medicines unit. The company also increased its full-year sales and profit forecast, following positive results from Johnson & Johnson, PNC Financial, and Elevance Health.
15 Jul, 10:27 — 15 Jul, 19:30
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (37/100)3 sources25/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left2
Left (2)
cnbcYahoo
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US3
ℹAll sources from US region
Sources
Showing 3 of 3 sources
cnbcMostly Factual24d ago
J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways
Johnson & Johnson's quarter was imperfect, but enough is going right to validate our ownership of the stock.
Read full article →YahooMostly Factual25d ago
J&J quarterly earnings beat Wall Street estimates on strength of medicines unit
Read full article →seeking-alphaMixed25d ago
Earnings Snapshot: Johnson & Johnson Q2 beats on top and bottom lines, hikes FY2026 guidance
Read full article →Coverage Timeline
First report: Yahoo · 15 Jul, 10:27|Full coverage: 3 · 9h|Window: 9h
Left-leaningCenterRight-leaning
